Acute renal failure associated with inhaled tobramycin

American Journal of Health-System Pharmacy

Volumn 63, Issue 19, 2006, Pages 1858-1861

  Cannella, Carrie A ^a   Wilkinson, Samaneh T ^a  

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

Author keywords

Aerosols; Aminoglycosides; Cilastatin; Dialysis; Drugs, adverse reactions; Imipenem; Kidney failure; TOBI; Tobramycin; Vancomycin

Indexed keywords

CILASTATIN PLUS IMIPENEM; CREATININE; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; CASE REPORT; CLINICAL FEATURE; CREATININE CLEARANCE; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS; HUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS;

EID: 33749183249     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060196     Document Type: Article

References (10)

1. Tacconelli E, Tumbarello M, Bertagnolio S et al. Multi-drug resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology. Emerg Infect Dis. 2002; 8:220-1.
2. Obritsch MD, Fish DN, MacLaren R et al. Nosocomial infections due to multidrug resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy. 2005; 25:1353-64.
3. American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171:388-416.
4. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
5. Hoffmann IM, Rubin BK, Iskander SS et al. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy. Pediatr Pulmonol. 2002; 34:375-7.
6. Kane-Gill SL, Kirisci L, Pathak DS. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit? Ann Pharmacother. 2005; 39:1823-7.
7. Ramsey BW, Dorkin HL, Eisenberg JD et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med. 1993; 328:1740-6.
8. Hudson ME, Gallagher CG, Govan JR. A randomized clinical trial of nebulized tobramycin or colistin in cystic fibrosis. Eur Respir J. 2002; 20:658-64.
9. Barker AF, Couch L, Fiel SB et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density of bronchiectasis. Am J Respir Crit Care Med. 2000; 162:481-5.
10. Drobnic ME, Sune P, Montoro JB et al. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother. 2005; 39:39-44.